Skip to main content
TOWA PHARMACEUTICAL CO.,LTD. logo

TOWA PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4553 ISIN · JP3623150004 LEI · 35380036BH1C3PNO2426 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2017-11-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4553

About TOWA PHARMACEUTICAL CO.,LTD.

https://www.towayakuhin.co.jp/english/

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and high added-value therapeutic solutions. Its product portfolio primarily consists of generic medications, which are distributed as ethical drugs, and also includes other products such as vitamins and antibiotics. The company focuses on the entire lifecycle of its pharmaceutical products, from initial development to final distribution, to meet various healthcare needs.

Recent filings

Filing Released Lang Actions
四半期報告書－第62期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the second quarter of the fiscal year ending March 31, 2018. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management's analysis of the financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2018
2017-11-14 Japanese
四半期報告書－第62期第1四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the first quarter of the 62nd fiscal year (April 1, 2017 to June 30, 2017). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2018
2017-08-10 Japanese
有価証券報告書－第61期(2016/04/01－2017/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management indicators, and corporate history for the fiscal year ending March 31, 2017. It is a comprehensive annual filing, not an announcement or a summary. FY 2017
2017-06-28 Japanese
四半期報告書－第61期第3四半期(2016/10/01－2016/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 61st fiscal period of Towa Pharmaceutical Co., Ltd. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-02-14 Japanese
四半期報告書－第61期第2四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the second quarter of the 61st fiscal period (April 1, 2016 to September 30, 2016). It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. It is a formal regulatory filing submitted to the Kinki Finance Bureau under the Financial Instruments and Exchange Act. This fits the definition of an Interim/Quarterly Report (IR). H1 2017
2016-11-10 Japanese
四半期報告書－第61期第1四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the first quarter of the fiscal year ending March 31, 2017 (covering April 1, 2016, to June 30, 2016). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, along with notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2017
2016-08-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.